What is GoodRx?
GoodRx Holdings, Inc. operates a comprehensive price comparison platform designed to empower consumers in the United States to save on prescription drug purchases. The company provides geographically relevant prescription pricing and access to negotiated rates, alongside a suite of healthcare products and services. These offerings include subscription models, pharma manufacturer solutions, and telehealth services via its GoodRx Care platform. GoodRx also serves pharmacy benefit managers, facilitating pricing agreements between consumers and pharmacies. Founded in 2011 and headquartered in Santa Monica, California, GoodRx has established itself as a critical tool for healthcare cost transparency.
How much funding has GoodRx raised?
GoodRx has raised a total of $2.2B across 3 funding rounds:
Angel/Seed
$1M
Stock Offering
$1.1B
Stock Offering
$1.1B
Angel/Seed (2012): $1M with participation from Highland Capital Partners, Lerer Ventures, and SV Angel
Stock Issuance/Offering (2020): $1.1B, investors not publicly disclosed
Stock Issuance/Offering (2020): $1.1B, investors not publicly disclosed
Key Investors in GoodRx
Highland Capital Partners
Highland Capital Partners is a venture capital firm known for investing in innovative startups and entrepreneurs, with a significant history of successful exits and IPOs.
Lerer Ventures
Lerer Ventures, operating as Kenneth Lerer Associates LLC, is a New York City-based venture capital firm focused on early-stage technology investments.
SV Angel
SV Angel is a long-term investment firm dedicated to supporting founders and providing strategic resources and network access to help companies scale.
What's next for GoodRx?
The recent major strategic investment in GoodRx signals a strong confidence from its backers in the company's future trajectory. This capital infusion is likely to fuel further expansion of its platform, enhance its telehealth offerings, and potentially explore new market segments within the healthcare ecosystem. Given the enterprise-level funding context, GoodRx appears to be in a scaling phase, focusing on solidifying its market leadership and innovating its service delivery to meet growing consumer demand for affordable healthcare solutions.
See full GoodRx company page
